Is SFC the Next Big Skincare Ingredient or Just the Next Big Promise

If you click on links we provide, we may receive compensation.

Thirty-two percent. That was the improvement in crow’s feet wrinkles reported after eight weeks of using a 1% gel of N-Succinyl-S-Farnesyl-L-Cysteine, a molecule most people have never heard of and few can pronounce. The comparison group using 5% niacinamide saw about 11%. Numbers like that get noticed fast, and they have. A longevity brand now sells SFC serums and moisturizers, and the ingredient is starting to show up in conversations about what comes after retinol, peptides, and niacinamide. So I went looking for the evidence behind the buzz, and what I found is more interesting – and more complicated – than the marketing suggests.

Here is the short version before we get into the details. SFC is a real molecule with a real research history and a plausible way of calming skin. It also has a thin clinical record that comes almost entirely from the company that owns it. Both of those things are true at once. If you have been around skincare long enough, you have seen this pattern before. A lab finding becomes a headline, the headline becomes a product, and the product arrives long before independent scientists have had a chance to check the work.

What exactly is N-Succinyl-S-Farnesyl-L-Cysteine?

SFC belongs to a family of small molecules called isoprenylcysteines, or IPCs. The structure is simple to describe. It is the amino acid cysteine with a 15-carbon chain called a farnesyl group attached, plus a succinyl group that changes how the molecule behaves. On a cosmetic label you will see it listed as disodium succinoyl farnesylcysteine. The design is meant to mimic the tail end of certain proteins inside cells that help pass signals from the cell surface to the inside.

Why would that matter for skin? Many of the signals that trigger redness, swelling, and irritation travel through proteins called G-proteins. Those proteins need a farnesyl-style anchor to sit in the right spot on the cell membrane and do their job. The theory behind SFC is that it can interfere with that signaling step and turn down the volume on inflammation before it gets going. That is a different approach from an antioxidant, which mops up damage after it starts, or a soothing botanical, which works on the surface. In plain terms, SFC is designed to quiet the alarm system rather than clean up after the fire.

The science behind this goes back decades. Jeffry Stock, a molecular biologist at Princeton University, modified S-farnesylcysteine into an active signaling molecule in 1991. He and his son Maxwell Stock founded Signum Biosciences in 2003 to turn that research into products. The company is based in Monmouth Junction, New Jersey, not far from the Princeton labs where the work started. It describes itself as a biopharmaceutical business focused on consumer and medical needs. Source: https://www.signumbiosciences.com/who-we-are

Is SFC really new or have we seen this before?

This is the part most of the current buzz leaves out. SFC is the newest member of a family that has been in skincare for more than a decade. In 2013, Elizabeth Arden signed a licensing deal with Signum’s skincare arm for an ingredient called Arazine. Its chemical name is N-acetyl-S-farnesyl-cysteine, or AFC, and it is a close cousin of SFC. Arden used it in its Prevage Anti-aging + Intensive Repair Daily Serum alongside idebenone. Source: https://www.cosmeticsbusiness.com/elizabeth-arden-partners-with-signum-dermalogix-86448

Signum also launched its own skincare brand, Epicutis, in 2020. That line uses another relative called QFC, or acetylglutaminoyl farnesylcysteine. QFC shows up in an eye mask positioned for hydration and dark circles. The company points to a 2016 lab study on how QFC affects water channels in skin cells. So Signum has now put at least three versions of the same core idea into finished products. Source: https://epicutis.com/pages/epicutis-exclusive-ingredients/qfc

So the farnesylcysteine idea has been on shelves before. It did not reshape the industry the way retinol or hyaluronic acid did. That does not mean SFC will fail. It does mean the question of whether it is the next big thing deserves a little more patience than a product page usually offers. If AFC was a breakthrough, I think we would have heard a lot more about it by now.

What did the main SFC study actually find?

The key paper appeared in the journal Cosmetics in November 2021. The lead researchers worked at Signum Biosciences, and Jeffry Stock of Princeton was a co-author. The team first tested SFC on human skin cells in the lab. They exposed keratinocytes, fibroblasts, blood vessel cells, and immune cells to triggers like UVB light, bacteria, chemicals, and an inflammatory peptide called cathelicidin. SFC reduced the release of inflammatory messengers in response to those triggers, and it cut UVA-driven production of collagenase, the enzyme that breaks down collagen. Source: https://www.mdpi.com/2079-9284/8/4/110

Then came the human trial. It was a 12-week, double-blind, split-face study with 49 Japanese women. Thirty-one of them applied 1% SFC gel to one side of the face and a plain vehicle gel to the other side, twice a day. The other 18 used 5% niacinamide on one side and vehicle on the other. At eight weeks, crow’s feet improved about 32% on the SFC side compared with about 6% for vehicle and about 11% for niacinamide. Radiance improved about 52% with SFC at 12 weeks versus about 22% with niacinamide, and hydration and firmness also moved in SFC’s favor. No adverse events were reported.

Those are good numbers! But read the design closely. The SFC and niacinamide groups were different people, not the same faces trying both, so this is not a true head-to-head test. The niacinamide group was small at 18 women. The improvements came from expert grading on a 10-point scale, which is standard in cosmetic research but still involves judgment. And the paper discloses that every author except Jeffry Stock held employment or equity in Signum. None of that makes the results false. It makes them preliminary.

Can SFC help with redness and rosacea?

This is where SFC might matter most, at least on paper. If the molecule works by calming inflammatory signaling, redness-prone skin is the obvious target. Rosacea is driven in part by the same cathelicidin peptide that SFC blocked in the lab. In 2023, the same research group published a short pilot report in the Journal of Cosmetic Dermatology. It found that SFC reduced redness and inflammatory bumps in people with rosacea. Source: https://doi.org/10.1111/jocd.15758

That is worth paying attention to. The National Rosacea Society estimates that at least 16 million Americans have rosacea, and many of them struggle to find products that do not sting. Source: https://www.rosacea.org/rosacea-review/2010/winter/rosacea-now-estimated-to-affect-at-least-16-million-americans. A cosmetic ingredient that calms flushing without irritation would fill a real need. But the 2023 publication is a pilot letter, not a full controlled trial. The authors were employees or consultants of Signum, which also funded the work. I would call it a promising lead, not an answer.

Who is selling SFC right now?

The most visible SFC products today come from Blueprint, the longevity brand founded by tech entrepreneur Bryan Johnson. Its SFC Facial Serum pairs SFC with sodium hyaluronate and NMN, a vitamin B3 derivative, and sells for $59 for one ounce. Blueprint also makes an SFC moisturizer and a cleanser with the ingredient. As far as I could find, those three are the only products on the market that list it right now. The serum page calls SFC five times more powerful than niacinamide. Source: https://blueprint.bryanjohnson.com/products/facial-serum

There is also one widely shared real-world test worth mentioning. A blogger named Josh applied the Blueprint serum to one half of his face twice a day for six months, from November 2025 to April 2026. He then asked people to guess which side had been treated, and their guesses split evenly. He saw no visible difference. Source: https://wp.josh.com/2026/04/22/i-used-blueprint-serum-on-half-my-face-for-6-months-can-you-tell-which-side/. One person’s face proves nothing about a population, and he did not have measuring tools. But it is a useful reminder that a trial result and a shopper’s mirror are two different things.

Why does SFC matter for mature skin?

Mature skin is where an anti-inflammatory active could earn its keep. Researchers use the term inflammaging to describe the low-level, chronic inflammation that builds as we get older. It contributes to collagen breakdown, uneven tone, and that easily irritated feeling many women notice after menopause. Skin also gets thinner and slower to recover with age. That is why so many people in their 50s, 60s, and beyond find that retinoids and acids they once used without trouble now leave them red and flaky.

An ingredient that calms inflammation and supports collagen without the irritation of retinol would be a genuinely useful tool for this group. The lab data showing SFC reduced UVA-driven collagenase fits that picture. The firmness result in the trial – about 19% improvement with SFC and none with niacinamide – fits it too. But the published study does not spell out the age range of the participants, so we do not know how well the results apply to women over 60 specifically. Older skin also has decades of sun damage that a 12-week trial cannot fully address.

My advice for mature skin is simple. Do not drop what already works to chase SFC. Daily broad-spectrum sunscreen, a barrier-supporting moisturizer with ceramides, and a retinoid or bakuchiol you tolerate still have far more evidence behind them. If you want to try SFC, add it as one extra step, keep everything else the same, and give it at least eight to 12 weeks. That is the only way to know whether it is doing anything for your skin.

How does SFC compare with niacinamide and retinol?

Niacinamide has been studied in dozens of trials by many independent groups over many years. It is cheap, stable, and well tolerated. Retinoids have even more evidence, including prescription tretinoin with decades of data on wrinkles and sun damage. SFC has one published cosmetic trial and one pilot letter, all from the company that developed it. On sheer depth of evidence, it is not a close contest yet.

Where SFC could stand out is tolerability and mechanism. Retinoids work by speeding cell turnover, which often causes peeling and stinging early on. Niacinamide can cause flushing in a small number of people at higher strengths. SFC is designed to work upstream on inflammatory signaling, and the 2021 study reported no adverse events at 1%. If larger, independent trials confirm that profile, SFC could become a useful option for people who cannot handle stronger actives. That is a meaningful role even if it never becomes the headline ingredient of the decade.

So is SFC the next big skincare ingredient?

My honest answer is not yet, and maybe not ever in the way the buzz implies. Big ingredients earn that status through years of independent research, wide availability from many brands, and results people can see. SFC has a clever mechanism and some encouraging early numbers. It also has a small evidence base, a single main supplier, and one consumer brand doing most of the talking. And its chemical cousin AFC has already had a turn in a prestige serum without changing the market.

What would change my mind? An independent trial with a larger and more varied group of participants, including women over 60 and people with different skin tones. A study that compares SFC directly against niacinamide or retinol on the same faces. Clear disclosure of SFC percentages in finished products. If those things happen and the results hold up, SFC could earn a lasting place on ingredient lists. Until then, I would treat it the way I treat most new actives, with curiosity and a little skepticism.

FAQs

What does SFC stand for in skincare?

SFC stands for N-Succinyl-S-Farnesyl-L-Cysteine. On ingredient labels it appears as disodium succinoyl farnesylcysteine. It is a small molecule designed to calm inflammatory signaling in skin cells.

Is SFC safe to use?

The 2021 clinical study of a 1% SFC gel reported no adverse events over 12 weeks of twice-daily use. That is encouraging, but the study was small. Patch test any new product, especially if you have sensitive or rosacea-prone skin.

Can I use SFC with retinol or vitamin C?

There is no published research on combining SFC with other actives. Because it is designed to calm rather than exfoliate, it is unlikely to add irritation, but no one has tested that formally. Introduce one new product at a time so you can tell what is working.

Is SFC better than niacinamide?

In one company-funded study, the SFC group showed bigger improvements than a separate niacinamide group. But the groups were different women, and niacinamide has far more independent evidence behind it. It is too early to call SFC better.

How long does SFC take to work?

In the published trial, wrinkle improvements showed up at eight weeks and radiance kept improving through 12 weeks. Plan on at least two to three months of consistent use before you judge results.

New ingredients are fun to follow, and SFC has a better backstory than most. It came out of real university research, it targets a real problem, and its early numbers look good. But one study does not make a revolution, and a product page is not a peer review. If you are curious, try it as an addition to a routine that already works, track your skin honestly, and keep your sunscreen in place. And keep an eye out for independent research, because that is what will decide whether SFC becomes a staple or a footnote.